Skip to content

IRM Cardiaque en Respiration Libre Pour Des Patients Atteints de Dystrophinopathie sévère

IRM Cardiaque en Respiration Libre Pour Des Patients Atteints de Dystrophinopathie sévère

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02078076
Enrollment
22
Registered
2014-03-05
Start date
2013-06-30
Completion date
2015-11-30
Last updated
2025-08-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Duchenne or Severe Becker Myopathy

Keywords

MRI, free-breathing acquisitions, myopathy, fibrosis assessment, function

Brief summary

Clinical, prospective and monocentric study aiming at assessing the feasibility of fibrosis detection and quantification (and of function assessment) during MRI without breath-holds in a population of adults and children with Duchenne myopathy.

Interventions

DEVICEMagnetic Resonance Cardiac Imaging (with Gadolinium)

Sponsors

Institut National de la Santé Et de la Recherche Médicale, France
Lead SponsorOTHER_GOV

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
8 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Dystophinopathy (Duchenne or severe Becker) * \>8yo * with social insurance * informed consent

Exclusion criteria

* arythmia * impossibility to undergo an MRI (pacemaker, ....)

Design outcomes

Primary

MeasureTime frameDescription
Number of exams correctly acquired (feasabiliy of the exam)after the last inclusionWas it possible to acquire the whole examination for every patient ?
Number of exams allowing a qualitative assessment of images by the physicianafter the last MRI examThe image quality allows a qualitative diagnosis ?
Number of exams allowing a quantitative assessment of the diagnosisafter the last MRI examinationDid the image quality allow a quantitative assessment of the diagnosis ?

Secondary

MeasureTime frameDescription
Number of anatomic cardiac segments with significant fibrosis according to the assessment methods (conventional LGE, qualitative detection with GRICS, and quantiative measure with GRICS)after the last inclusioncorrelation between fibrosis information (conventional LGE, qualitative detection with GRICS, and quantiative measure with GRICS)
Number of cardiac segments with fibrosis and/or regional dysfunctionafter the last inclusionCorrelation between fibrosis and regional function for each cardiac segment

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026